Document Detail


Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation.
MedLine Citation:
PMID:  10376526     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Overexpression of the receptor tyrosine kinase ErbB2/HER2/Neu (ErbB2) occurs in 15-40% of human breast cancers. To determine the function of ErbB2 signaling during normal mouse mammary gland development, we expressed a carboxyl-terminal truncated dominant negative allele of ErbB2 (ErbB2deltaIC) in the developing mouse mammary gland. Despite ErbB2deltaIC expression within mammary glands of pubescent virgin and pregnant mice, a phenotype was not observed until late in pregnancy. At 1 day post-partum, lactationally active, distended lobuloalveoli failed to form. This phenotype was exaggerated in multiparous females expressing ErbB2deltaIC. Immunohistochemical staining for ErbB2deltaIC revealed a concordance between high levels of ErbB2deltaIC protein expression and the absence of lactational products within the lumens of ErbB2deltaIC stained lobuloalveoli. These results demonstrate that ErbB2 signaling is required for proper mammary development and lactation at parturition.
Authors:
F E Jones; D F Stern
Related Documents :
1000606 - Freeze-etching studies on ultrastructural changes of endothelial cells in the thyroid o...
10959406 - Expression and localization of growth factors during mammary gland development.
21075976 - Proanthocyanidins inhibit uv-induced immunosuppression through il-12-dependent stimulat...
2761236 - Mammary gland growth and response to hormones in mastomys compared with mice.
12882316 - Severe cognitive and motor coordination deficits in tenascin-r-deficient mice.
15622466 - Effect of intraperitoneal neutrophils induced by ok432 on malignant ascites.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Oncogene     Volume:  18     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-06-30     Completed Date:  1999-06-30     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  3481-90     Citation Subset:  IM    
Affiliation:
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3T3 Cells
Animals
Female
Lactation / physiology*
Mammary Glands, Animal / growth & development*,  metabolism
Mice
Mice, Transgenic
Phenotype
Phosphorylation
Pregnancy
Rats
Receptor, erbB-2 / chemistry,  metabolism,  physiology*
Signal Transduction
Grant Support
ID/Acronym/Agency:
R01CA45708/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
EC 2.7.10.1/Receptor, erbB-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals ...
Next Document:  Role of the ATFa/JNK2 complex in Jun activation.